PAVM - パブメッド （PAVmed Inc.） パブメッドPAVMのチャート
PAVMの企業情報
| symbol | PAVM |
|---|---|
| 会社名 | PAVmed Inc （パブメッド） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 パブメッド(PAVmed Inc.)は医療器械会社である。同社の製品はPortIO、Caldus、CarpX、NextCath及びNextFloを含む。PortIOは中心静脈システムにアクセスする必要がなくて、留置血管内のコンポーネントを持たない長期移植可能な血管アクセスデバイスである。Caldusは高血圧症治療用の腎臓神経除去のために応用された使い捨ての組織アブレーション装置である。CarpXは手根管症候群を治療するための経皮デバイスである。NextCathは縫合、従来の係留技術またはアドオンカテーテル固定器具を必要をしない自己固着カテーテルである。同社は貯蔵したポテンシャルエネルギーと可変流量抵抗を用いて使い捨て輸液ポンプを開発する。同社は完成した概念実証の作業、及びそのアプローチ、輸液装置及びバルーンカテーテルのワーキングプロトタイプを検証する熱有限要素解析シミュレーションを有する。 パブメッドは米国の医療装置・機器メ―カ―。同社パイプライン製品には皮下埋め込み型血管ポ―ト、高血圧治療の腎交感神経除神経術のための使い捨て組織除去装置、手根管症候群治療のための経皮装置、カテ―テル確保のための装置を必要としない自己アンカ―・カテ―テルなどを含む。本社はニューヨーク。 PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. PAVmed's diversified pipeline of products address unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its five lead technologies provide groundbreaking approaches to carpal tunnel syndrome (CarpX™), precancerous conditions of the esophagus (EsoGuard™/EsoCheck™), vascular access (PortIO™), pediatric ear infections (DisappEAR™) and medical infusions (NextFlo™). The company is also developing innovative products in other areas, such as catheters and tissue ablation, while seeking to further expand its pipeline through engagements with clinician innovators and leading academic medical centers. |
| 本社所在地 | One Grand Central Place Suite 4600 New York NY 10165 USA |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | +1 212-949-4319 |
| 設立年月日 | 41791 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2016年 |
| 従業員数 | 6人 |
| url | www.pavm.com |
| nasdaq_url | https://www.nasdaq.com/symbol/pavm |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -8.53171 |
| 終値（lastsale） | 1.2198 |
| 時価総額（marketcap） | 32377125.7842 |
| 時価総額 | 時価総額（百万ドル） 31.32072 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 24.62638 |
| 当期純利益 | 当期純利益（百万ドル） -13.60428 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 PAVmed Inc revenues was not reported. Net loss applicable to common stockholders increased 60% to $8.5M. Higher net loss reflects Change in fair value of Series A Warrant decrease from $1.5M (income) to $96K (expense) Change in fair value of Series A Convert decrease of 87% to $65K (income). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.40 to -$0.47. |
PAVMのテクニカル分析
PAVMのニュース
Is PAVmed Inc. (NASDAQ:PAVM), -368.0% Away From High, Poised For A Strong Comeback? 2023/01/28 17:00:00 Marketing Sentinel
In last trading session, PAVmed Inc. (NASDAQ:PAVM) saw 0.54 million shares changing hands with its beta currently measuring 0.86. Company’s recent per share price level of $0.50 trading at $0.02 or 5.21% at ring of the bell on the day assigns it a market valuation of $47.62M. That closing price of PAVM’s stock is at … Is PAVmed Inc. (NASDAQ:PAVM), -368.0% Away From High, Poised For A Strong Comeback? Read More »
Foolproof stocks: PAVmed Inc. (NASDAQ:PAVM 5.21%), Hecla Mining Company (NYSE:HL -2.04%) 2023/01/28 12:54:50 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Foolproof stocks: PAVmed Inc. (NASDAQ:PAVM 5.21%), Hecla Mining Company (NYSE:HL -2.04%) appeared first on Stocks Equity .
Is PAVmed Inc. (NASDAQ: PAVM) Hit More of the Losses Given A -408.7% Dip From High? 2023/01/21 20:00:00 Marketing Sentinel
During the last session, PAVmed Inc. (NASDAQ:PAVM)’s traded shares were 0.55 million, with the beta value of the company hitting 0.88. The 52-week high for the PAVM share is $2.34, that puts it down -408.7 from that peak though still a striking 13.04% gain since the share price plummeted to a 52-week low of $0.40. … Is PAVmed Inc. (NASDAQ: PAVM) Hit More of the Losses Given A -408.7% Dip From High? Read More »
Benzinga''s Top Ratings Upgrades, Downgrades For January 20, 2023 2023/01/20 15:00:42 Benzinga
Upgrades For Par Pacific Holdings Inc (NYSE: PARR ), Piper Sandler upgraded the previous rating of Neutral to Overweight. In the third quarter, Par Pacific Hldgs showed an EPS of $2.88, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $25.38 and a 52-week-low of $11.66. At the end of the last trading period, Par Pacific Hldgs closed at $24.54. For Regeneron Pharmaceuticals Inc (NASDAQ: REGN ), JP Morgan upgraded the previous rating of Neutral to Overweight. Regeneron Pharmaceuticals earned $11.14 in the third quarter, compared to $15.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $779.00 and a 52-week-low of $538.01. Regeneron Pharmaceuticals closed at $715.57 at the end of the last trading period. For PVH Corp (NYSE: PVH ), Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, PVH showed an EPS of $2.60, compared to $2.67 from the year-ago quarter. The stock has a 52-week-high of $105.43 and a 52-week-low of $43.49.
Cantor Fitzgerald Downgrades PAVmed to Neutral 2023/01/20 11:49:01 Investing.com
https://www.investing.com/news/pro/cantor-fitzgerald-downgrades-pavmed-to-neutral-432SI-2984627
PAVmed Inc. (NASDAQ: PAVM): How Can A Stock Be Down -79.47% Year To Date, But Still Loser 2022/12/24 15:30:00 Marketing Sentinel
PAVmed Inc. (NASDAQ:PAVM)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 0.76. At the close of trading, the stock’s price was $0.51, to imply a decrease of -6.81% or -$0.03 in intraday trading. The PAVM share’s 52-week high remains $2.92, putting it -472.55% down since that peak … PAVmed Inc. (NASDAQ: PAVM): How Can A Stock Be Down -79.47% Year To Date, But Still Loser Read More »
Results from PAVmed Inc. (PAVM) show potential 2022/12/22 16:24:00 US Post News
As of Wednesday, PAVmed Inc.’s (NASDAQ:PAVM) stock closed at $0.51, up from $0.50 the previous day. While PAVmed Inc. has overperformed by 1.21%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PAVM fell by -83.41%, with highs and lows ranging from $3.13 to $0.49, whereas the […]
PAVmed Partners with Novosound on Ultrasound Imaging Technology 2022/12/22 13:25:00 Wallstreet:Online
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has entered into a license option and joint research and development agreement with Novosound Ltd. (“Novosound”), a venture-backed technology company based in Glasgow, Scotland, to explore
PAVmed Inc. (NASDAQ:PAVM) jumps 10.40% In 2022; How Attractive Is It At $0.52? 2022/12/17 16:00:00 Marketing Sentinel
In last trading session, PAVmed Inc. (NASDAQ:PAVM) saw 0.74 million shares changing hands with its beta currently measuring 0.71. Company’s recent per share price level of $0.52 trading at $0.01 or 1.29% at ring of the bell on the day assigns it a market valuation of $49.38M. That closing price of PAVM’s stock is at … PAVmed Inc. (NASDAQ:PAVM) jumps 10.40% In 2022; How Attractive Is It At $0.52? Read More »
PAVmed Digital Health subsidiary launches Veris cancer care platform 2022/12/15 16:49:45 Seeking Alpha
PAVmed (PAVM) said on Thursday digital health subsidiary Veris Health had commercially launched its Veris Cancer Care Platform. Veris CCP is a digital cancer care platform with…
PAVmed Inc. (NASDAQ: PAVM): How Can A Stock Be Down -79.47% Year To Date, But Still Loser 2022/12/24 15:30:00 Marketing Sentinel
PAVmed Inc. (NASDAQ:PAVM)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 0.76. At the close of trading, the stock’s price was $0.51, to imply a decrease of -6.81% or -$0.03 in intraday trading. The PAVM share’s 52-week high remains $2.92, putting it -472.55% down since that peak … PAVmed Inc. (NASDAQ: PAVM): How Can A Stock Be Down -79.47% Year To Date, But Still Loser Read More »
Results from PAVmed Inc. (PAVM) show potential 2022/12/22 16:24:00 US Post News
As of Wednesday, PAVmed Inc.’s (NASDAQ:PAVM) stock closed at $0.51, up from $0.50 the previous day. While PAVmed Inc. has overperformed by 1.21%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PAVM fell by -83.41%, with highs and lows ranging from $3.13 to $0.49, whereas the […]
PAVmed Partners with Novosound on Ultrasound Imaging Technology 2022/12/22 13:25:00 Wallstreet:Online
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it has entered into a license option and joint research and development agreement with Novosound Ltd. (“Novosound”), a venture-backed technology company based in Glasgow, Scotland, to explore
PAVmed Inc. (NASDAQ:PAVM) jumps 10.40% In 2022; How Attractive Is It At $0.52? 2022/12/17 16:00:00 Marketing Sentinel
In last trading session, PAVmed Inc. (NASDAQ:PAVM) saw 0.74 million shares changing hands with its beta currently measuring 0.71. Company’s recent per share price level of $0.52 trading at $0.01 or 1.29% at ring of the bell on the day assigns it a market valuation of $49.38M. That closing price of PAVM’s stock is at … PAVmed Inc. (NASDAQ:PAVM) jumps 10.40% In 2022; How Attractive Is It At $0.52? Read More »